Shandong Pharmaceutical Glass Co.Ltd announced that it has signed Share Subscription Agreement to issue not more than 199,084,233 A shares at an issue price of CNY 16.25 per share for gross proceeds of CNY 3,235,118,786.25 on January 13, 2026. The transaction will include participation from China Sinopharm International Corporation for 156,007,310 A shares, Shandong Yaoxin Health Industry Co., Ltd. for 43,076,923 A shares. The shares cannot be transferred within 18 months from the issuance closing date.
The total proceeds to be raised are not more than CNY 3,235,118,800. The transaction is approved by board of directors of the company in 5th Meeting of the Company?s 11th Directorate, and is subject to the approvals of the Company?s Shareholders, the authorized state-owned assets supervision and management department, the Shanghai Stock Exchange, and the China Securities Regulatory Commission.
